Challenges in Treatment of Desmoid Tumors and Managed Care Solutions | PTCE Pharmacy Connect - Video

Source:
https://www.podbean.com/eau/pb-pqxp4-14efa81

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
Challenges in Treatment of Desmoid Tumors and Managed Care Solutions
 
Educational Objectives
Recall the key characteristics of desmoid tumors (DT), including presentation, frequency, genetic mutations, development, and outlook for individual patients
Outline practical solutions to improve managed care-driven communication with health care providers and address the clinical and financial burden of unresectable, recurrent DT
 


Laura Bobolts, PharmD, BCOP
Senior Vice President of Clinical Strategy and Growth
OncoHealth
Plantation, Florida


 
Faculty:
Christy Harris, PharmD, BCOP, FHOPA    
Clinical Pharmacy Specialist                                                               
Dana-Farber Cancer Institute
Associate Professor
Massachusetts College of Pharmacy and Health Sciences
Boston, Massachusetts
 
Christy Harris, PharmD, BCOP, FHOPA and Laura Bobolts, PharmD, BCOP have no financial relationships with commercial interests to disclose.
 
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-23-421-H01-P. The activity is available for CE credit through November 30, 2024.
 
This activity is supported by an educational grant from SpringWorks Therapeutics.